This suggests that the activation of the lysosomal pathway, which includes the ACP5 gene that was significantly up‐regulated in BL001‐treated T1D M1 (Figure 2B,F, red arrows), may be involved in suppressing the pro‐inflammatory phenotype. This evidence concerns the gene ACP5 and type 1 diabetes mellitus.